A small change to a powerful molecular tool — using the CRISPR-Cas13 enzyme, which can detect RNA from viruses and cells — ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) surpasses market returns: Some facts worth knowing
In the latest close session, CRISPR Therapeutics AG (CRSP) was up +2.7% at $51.31. This move outpaced the S&P 500's daily gain of 0.54%. Elsewhere, the Dow saw an upswing of 1.05%, while the ...
Researchers have developed a new biomimetic nanocomposite (mPDA-Cas9) for treating triple-negative breast cancer (TNBC) by combining CRISPR/Cas9 gene ...
GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests ...
Colossal Biosciences has achieved a de-extinction milestone, revealing three genetically engineered 'dire wolf' pups. Learn ...
Colossal Biosciences is applying genetics and long-term biostorage to conservation efforts, with research also exploring ...
For San Diego researchers and the wider immunotherapy community, the atlas functions as a practical roadmap. It does not ...
Over the next two years, the planned funding will be allocated to projects that have received some FDA feedback as well as emerging efforts.
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel ...
The United Arab Emirates and Colossal Biosciences have announced the creation of the first Colossal BioVault and World ...
Jeffrey Epstein's emails reveal a human cloning experiment linked to a Ukrainian lab Read Full Article at RT.com ...
Venkatesan Sundaresan, a distinguished professor of plant biology and plant sciences at UC Davis, has been awarded a Gates Foundation grant to develop self-cloning crops for Indian farmers.The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果